LATEST ALERTS
UK-based medical cannabis company Kanabo will look to focus on “last mile assets” such as dispensing and prescribing as it responds to changing market conditions. That change of emphasis, announced during the company’s presentation of its 2021 year end results, is reflected in recent acquisition activity.
But the £36m purchase of Materia, a processor and distributor of medical cannabis and CBD wellness products, that had been in the works for about a year, has been scrapped in favour of a strategic partnership.
